ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GRML vs PTHS // GROSS PROFIT MARGIN

Greenland Mines Ltd. (NASDAQ) VS. Pelthos Therapeutics Inc. (NYSE) • 15-METRIC TALLY: GRML 2 — PTHS 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRML VS. PTHS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GRML PTHS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 76.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.37% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 PTHS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.0 21.8 +17.12 GRML /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $70.3M $63.3M $7.0M GRML /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GRML REV PTHS REV GRML GROSS % PTHS GROSS % GRML FCF PTHS FCF
FY 2025 $0 $16.8M — 76.3% -$5.9M -$22.7M
FY 2024 $0 $0 — — -$2.9M -$5.8M
FY 2023 $0 $0 — — -$446.9K -$981.0K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRML // BETA —
PTHS // BETA —